Physician

Jesse Jung, MD

According to 2025 Medicare claims, Jesse Jung, MD (NPI: 1033351689) practices ophthalmology in the Oakland-Fremont-Berkeley, CA market, with the plurality of this provider's patient population coming from Alameda, CA. This provider's primary affiliated billing organization is EAST BAY RETINA CONSULTANTS A MEDICAL GROUP, INC. (NPI: 1790965341; TIN: 943209895) and primary practice location at 94583-5406.

Jung's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 987 traditional Medicare patients, billed 36,561 HCPCS/CPT codes, and received $2,320,919 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 349 prescription claims across 86 beneficiaries totaling $22,864 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 35 records totaling $19,290. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $92,165 to $2,320,919. Similarly, Part D prescription costs have risen steadily, from $7,089 to $22,864. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.2M$2.3M2015 Medicare payment: $92,165 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $674,038 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,085,100 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,206,804 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,494,836 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,428,558 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,578,835 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,727,294 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,798,018 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,320,919 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015206985$92,165
20165704,737$674,038
20176227,119$1,085,100
20187118,353$1,206,804
201984010,785$1,494,836
20207837,864$1,428,558
20218398,800$1,578,835
202292710,531$1,727,294
202384819,949$1,798,018
202498736,561$2,320,919

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$23K$45K2015 Drug cost: $7,089 (USD; Tot_Drug_Cst)2016 Drug cost: $7,372 (USD; Tot_Drug_Cst)2017 Drug cost: $45,011 (USD; Tot_Drug_Cst)2018 Drug cost: $15,360 (USD; Tot_Drug_Cst)2019 Drug cost: $11,549 (USD; Tot_Drug_Cst)2020 Drug cost: $12,392 (USD; Tot_Drug_Cst)2021 Drug cost: $20,692 (USD; Tot_Drug_Cst)2022 Drug cost: $21,630 (USD; Tot_Drug_Cst)2023 Drug cost: $18,518 (USD; Tot_Drug_Cst)2024 Drug cost: $22,864 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201534109$7,089
201652149$7,372
201761255$45,011
201878330$15,360
201975259$11,549
202067206$12,392
202175315$20,692
202287340$21,630
202377288$18,518
202486349$22,864

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more439714$118
67028Injection of drug into eye3111,658$113
92014Established patient complete exam of visual system445453$110
92134Imaging of retina9732,703$38
92202Extended exam of the back part of the eye with optic nerve drawing498747$14

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate714,653$3,851
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat553,786$886
Ketorolac TromethamineKetorolac Tromethamine432,646$734
LatanoprostLatanoprost433,658$703
Brimonidine TartrateBrimonidine Tartrate161,122$425

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.35$19,290Chugai Pharmaceutical Co., Ltd.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Jesse Jung, MD?

Tedicare shows public-source Medicare data for Jesse Jung, MD (NPI 1033351689), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jesse Jung, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Jesse Jung, MD?

Jesse Jung, MD is linked to EAST BAY RETINA CONSULTANTS A MEDICAL GROUP, INC. (billing NPI 1790965341) in the available physician profile data.

Does Jesse Jung, MD have Open Payments data?

Jesse Jung, MD has 35 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.